Evidence map›Paper›PMID 17485519›Full record

ArticleThe Journal of experimental medicine2007

A primary immunodeficiency characterized by defective immunoglobulin class switch recombination and impaired DNA repair.

Sophie Péron, Qiang Pan-Hammarström, Kohsuke Imai, Likun Du, Nadine Taubenheim, Ozden Sanal, Laszlo Marodi, Anne Bergelin-Besançon, Malika Benkerrou, Jean-Pierre de Villartay and 3 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of experimental medicine, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. New frontiers of primary antibody deficiencies.Cellular and molecular life sciences : CMLS · 2012
    Review
  12. Update on the hyper immunoglobulin M syndromes.British journal of haematology · 2010
    Review
  13. Article
  14. Non-homologous end joining in class switch recombination: the beginning of the end.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2009
    Review
  15. Immunoglobulin class switch recombination: study through human natural mutants.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2009
    Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 5 countries.

Sophie PéronInstitut National de la Santé et de la Recherche Médicale, U768, Paris, France.
Qiang Pan-Hammarström
Kohsuke Imai
Likun Du
Nadine Taubenheim
Ozden Sanal
Laszlo Marodi
Anne Bergelin-Besançon
Malika Benkerrou
Jean-Pierre de Villartay
Alain Fischer
Patrick Revy
Anne Durandy
Hôpital Necker-Enfants Malades · FRInserm · FRKarolinska University Hospital · SECentre Hospitalier du Mans · FRDélégation Paris 5 · FRHacettepe University Hospital · TRNational Defense Medical College · JPUniversité Paris Cité · FRUniversity of Debrecen · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunoglobulin class switch recombination (CSR) deficiencies are rare primary immunodeficiencies, characterized by a lack of switched isotype (IgG, IgA, or IgE) production, variably associated with abnormal somatic hypermutation (SHM). Deficiencies in CD40 ligand, CD40, activation-induced cytidine deaminase, and uracil-N-glycosylase may account for this syndrome. We previously described another Ig CSR deficiency condition, characterized by a defect in CSR downstream of the generation of double-stranded DNA breaks in switch (S) mu regions. Further analysis performed with the cells of five affected patients showed that the Ig CSR deficiency was associated with an abnormal formation of the S junctions characterized by microhomology and with increased cell radiosensitivity. In addition, SHM was skewed toward transitions at G/C residues. Overall, these findings suggest that a unique Ig CSR deficiency phenotype could be related to an as-yet-uncharacterized defect in a DNA repair pathway involved in both CSR and SHM events.

Indexed as

Antigens, CD19Base PairingBase SequenceB-LymphocytesChildChild, PreschoolDNA-Binding ProteinsDNA Breaks, Double-StrandedDNA RepairDNA Repair EnzymesFemaleFibroblastsGamma RaysHumansImmunoglobulin Class SwitchingImmunoglobulin MAntigens, CD19DNA-Binding ProteinsDNA Repair EnzymesImmunoglobulin MNHEJ1 protein, humanTumor Necrosis Factor Receptor Superfamily, Member 7

Identifiers

PMID17485519
PMCPMC2118580
OpenAlexW2007954723

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.